Ferric Carboxymaltose Injection Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 50 mg/mL

Reference Brands: Injectafer

Category: Anemia

Ferric Carboxymaltose Injection (Injectafer®/Ferinject®) is an intravenous iron therapy for treating iron deficiency anemia. With a concentration of 50 mg/mL, it allows for large, single-dose infusions. It is widely used in hospitals and clinics across the U.S. and EU. Ferric Carboxymaltose Injection is available in Injection and strengths such as 50 mg/mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Ferric Carboxymaltose Injection is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Ferric Carboxymaltose Injection can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description:

Ferric Carboxymaltose Injection (brand names Injectafer® in the U.S. and Ferinject® in the EU) is a high-concentration intravenous iron therapy used to treat iron deficiency anemia, particularly in patients who cannot tolerate oral iron or need rapid iron repletion. With a strength of 50 mg/mL, it allows for large, single-dose infusions, enhancing patient convenience and adherence. In the U.S. and EU, Ferric Carboxymaltose is in high demand across hospitals, dialysis centers, and specialty clinics. In the pharmaceutical B2B sector, it is supplied by licensed manufacturers, contract partners, and distributors to meet institutional needs and ensure global availability.